- Home
- ADMA vs QLYS Comparison
ADMA vs QLYS Comparison
Compare ADMA & QLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- QLYS
- Stock Information
- Founded
- ADMA 2004
- QLYS 1999
- Country
- ADMA United States
- QLYS United States
- Employees
- ADMA N/A
- QLYS N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- QLYS Computer Software: Prepackaged Software
- Sector
- ADMA Health Care
- QLYS Technology
- Exchange
- ADMA Nasdaq
- QLYS Nasdaq
- Market Cap
- ADMA 5.1B
- QLYS 4.4B
- IPO Year
- ADMA N/A
- QLYS 2012
- Fundamental
- Price
- ADMA $18.51
- QLYS $135.83
- Analyst Decision
- ADMA Strong Buy
- QLYS Hold
- Analyst Count
- ADMA 3
- QLYS 17
- Target Price
- ADMA $27.67
- QLYS $137.36
- AVG Volume (30 Days)
- ADMA 3.3M
- QLYS 314.5K
- Earning Date
- ADMA 08-07-2025
- QLYS 08-05-2025
- Dividend Yield
- ADMA N/A
- QLYS N/A
- EPS Growth
- ADMA N/A
- QLYS 13.46
- EPS
- ADMA 0.84
- QLYS 4.89
- Revenue
- ADMA $459,381,000.00
- QLYS $621,665,000.00
- Revenue This Year
- ADMA $23.35
- QLYS $9.64
- Revenue Next Year
- ADMA $27.67
- QLYS $6.65
- P/E Ratio
- ADMA $22.16
- QLYS $27.73
- Revenue Growth
- ADMA 62.23
- QLYS 9.14
- 52 Week Low
- ADMA $10.21
- QLYS $112.61
- 52 Week High
- ADMA $25.67
- QLYS $170.00
- Technical
- Relative Strength Index (RSI)
- ADMA 46.05
- QLYS 42.35
- Support Level
- ADMA $17.90
- QLYS $146.76
- Resistance Level
- ADMA $18.69
- QLYS $151.10
- Average True Range (ATR)
- ADMA 0.62
- QLYS 3.30
- MACD
- ADMA 0.10
- QLYS -0.60
- Stochastic Oscillator
- ADMA 74.12
- QLYS 11.55
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About QLYS Qualys Inc.
Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.